Search results for: Health Policy and Regulation
Filter search results
The New Global Economics of Vaccines: Will the Scientific Potential Be Realised?
1 January 2007
…supplier. Research indicates that this has been the result of the interaction of supply and demand and, in particular, of the special characteristics of demand and supply in this industry….
Prevention pays off – so why aren’t we doing more of it?
5 June 2025
…and increasing the effectiveness of programme delivery by expanding vaccination options and integrating vaccinations into routine health check-ups. Most importantly, we need to pivot our thinking towards viewing health as…
New: Pay-for-Performance for Drugs and Incentives for Innovation
27 February 2012
…is highly controversial and is disliked by many health care providers, policy makers, and pharmaceutical companies. Interest is growing in schemes that involve “paying for pills by results”, that is,…
New Research on VBP: Disease Severity and Unmet Need in the UK
24 April 2012
…been studied adequately (or perhaps at all) to date, either in the UK or elsewhere. The Department of Health’s Policy Research Unit in Economic Evaluation of Health and Care Interventions…
OHE has an Opening for an Economist — Consultancy and Research
23 May 2012
…research and consultancy activities. Our work covers a broad range of analyses into the economics and policy of: (1) health care systems, (2) pharmaceutical and other life sciences industries, and…
Register Now for the OHE Conference on Drug Development in 2022
14 August 2012
…of UK and EU regulatory agencies, the pharmaceutical industry and payers — as well as leading experts in health technology assessment, pricing and reimbursement, and R&D structure and incentives. Among…
OHE Conference on the Future of Drug Development – Register Now
5 September 2012
…of UK and EU regulatory agencies, the pharmaceutical industry and payers — as well as leading experts in health technology assessment, pricing and reimbursement, and R&D structure and incentives. Among…
Victoria Jordan
3 February 2023
Victoria Jordan is Head of HTA and Market Access Policy at the Association of the British Pharmaceutical Industry (ABPI) which he joined in November 2017.
Join OHE in a Seminar to Discuss IP, Innovation and the Human Genome
19 October 2012
…in the context of existing theoretical and empirical research, and comment on the implications of these findings for public policy. Prof Williams is an Assistant Professor of Economics at the…